NCT02496650View on ClinicalTrials.gov

Dexmedetomidine Addition to Benzodiazepines for Patients With Alcohol Withdrawal State in the ICU

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

June 30, 2015

Conditions
Alcohol Withdrawal State
Interventions
DRUG

Dexmedetomidine

DEX infusion in doses 0,2-1,4 μg/kg/hr

All Listed Sponsors
lead

Bogomolets National Medical University

OTHER

NCT02496650 - Dexmedetomidine Addition to Benzodiazepines for Patients With Alcohol Withdrawal State in the ICU | Biotech Hunter | Biotech Hunter